nodes	percent_of_prediction	percent_of_DWPC	metapath
Tapentadol—HTR3A—migraine	0.323	0.716	CbGaD
Tapentadol—SLC6A4—migraine	0.128	0.284	CbGaD
Tapentadol—OPRD1—Amitriptyline—migraine	0.0491	0.121	CbGbCtD
Tapentadol—UGT1A9—Valproic Acid—migraine	0.0447	0.11	CbGbCtD
Tapentadol—UGT2B7—Valproic Acid—migraine	0.0423	0.104	CbGbCtD
Tapentadol—OPRK1—Amitriptyline—migraine	0.041	0.101	CbGbCtD
Tapentadol—OPRM1—Amitriptyline—migraine	0.0362	0.0893	CbGbCtD
Tapentadol—SLC6A4—Amitriptyline—migraine	0.0299	0.0738	CbGbCtD
Tapentadol—SLC6A2—Amitriptyline—migraine	0.025	0.0618	CbGbCtD
Tapentadol—SLC6A4—Verapamil—migraine	0.0237	0.0586	CbGbCtD
Tapentadol—CYP2C19—Timolol—migraine	0.0128	0.0316	CbGbCtD
Tapentadol—CYP2C19—Propranolol—migraine	0.0114	0.0282	CbGbCtD
Tapentadol—CYP2C19—Amitriptyline—migraine	0.00986	0.0244	CbGbCtD
Tapentadol—CYP2D6—Timolol—migraine	0.00973	0.024	CbGbCtD
Tapentadol—CYP2C19—Valproic Acid—migraine	0.00899	0.0222	CbGbCtD
Tapentadol—CYP2D6—Propranolol—migraine	0.00867	0.0214	CbGbCtD
Tapentadol—CYP2C9—Amitriptyline—migraine	0.0082	0.0202	CbGbCtD
Tapentadol—CYP2C19—Topiramate—migraine	0.00811	0.02	CbGbCtD
Tapentadol—CYP2C19—Verapamil—migraine	0.00783	0.0193	CbGbCtD
Tapentadol—CYP2D6—Amitriptyline—migraine	0.0075	0.0185	CbGbCtD
Tapentadol—CYP2C9—Valproic Acid—migraine	0.00747	0.0185	CbGbCtD
Tapentadol—CYP2C9—Verapamil—migraine	0.00651	0.0161	CbGbCtD
Tapentadol—CYP2D6—Verapamil—migraine	0.00595	0.0147	CbGbCtD
Tapentadol—SLC6A2—locus ceruleus—migraine	0.00282	0.126	CbGeAlD
Tapentadol—HTR3A—cranial nerve—migraine	0.00245	0.11	CbGeAlD
Tapentadol—SLC6A2—sympathetic nervous system—migraine	0.00223	0.1	CbGeAlD
Tapentadol—SLC6A2—autonomic nervous system—migraine	0.0015	0.0672	CbGeAlD
Tapentadol—HTR3A—nerve—migraine	0.00126	0.0563	CbGeAlD
Tapentadol—OPRM1—nerve—migraine	0.00115	0.0516	CbGeAlD
Tapentadol—SLC6A2—nerve—migraine	0.000843	0.0378	CbGeAlD
Tapentadol—HTR3A—trigeminal ganglion—migraine	0.000609	0.0273	CbGeAlD
Tapentadol—HTR3A—brainstem—migraine	0.000539	0.0242	CbGeAlD
Tapentadol—OPRM1—brainstem—migraine	0.000494	0.0222	CbGeAlD
Tapentadol—SLC6A4—brainstem—migraine	0.000411	0.0184	CbGeAlD
Tapentadol—OPRD1—head—migraine	0.0004	0.018	CbGeAlD
Tapentadol—OPRK1—head—migraine	0.000384	0.0172	CbGeAlD
Tapentadol—OPRD1—nervous system—migraine	0.00038	0.017	CbGeAlD
Tapentadol—OPRD1—central nervous system—migraine	0.000365	0.0164	CbGeAlD
Tapentadol—OPRK1—nervous system—migraine	0.000364	0.0163	CbGeAlD
Tapentadol—SLC6A2—brainstem—migraine	0.000362	0.0162	CbGeAlD
Tapentadol—OPRK1—central nervous system—migraine	0.00035	0.0157	CbGeAlD
Tapentadol—OPRK1—cerebellum—migraine	0.000342	0.0154	CbGeAlD
Tapentadol—HTR3A—head—migraine	0.000298	0.0134	CbGeAlD
Tapentadol—OPRD1—brain—migraine	0.00029	0.013	CbGeAlD
Tapentadol—HTR3A—nervous system—migraine	0.000282	0.0127	CbGeAlD
Tapentadol—OPRK1—brain—migraine	0.000278	0.0125	CbGeAlD
Tapentadol—OPRM1—head—migraine	0.000273	0.0122	CbGeAlD
Tapentadol—HTR3A—central nervous system—migraine	0.000272	0.0122	CbGeAlD
Tapentadol—OPRM1—nervous system—migraine	0.000259	0.0116	CbGeAlD
Tapentadol—OPRM1—central nervous system—migraine	0.000249	0.0112	CbGeAlD
Tapentadol—SLC6A4—head—migraine	0.000227	0.0102	CbGeAlD
Tapentadol—HTR3A—brain—migraine	0.000216	0.00968	CbGeAlD
Tapentadol—CYP2C9—cardiovascular system—migraine	0.000215	0.00966	CbGeAlD
Tapentadol—SLC6A4—nervous system—migraine	0.000215	0.00966	CbGeAlD
Tapentadol—SLC6A4—central nervous system—migraine	0.000207	0.0093	CbGeAlD
Tapentadol—SLC6A2—head—migraine	0.0002	0.00897	CbGeAlD
Tapentadol—CYP2D6—brainstem—migraine	0.000198	0.00888	CbGeAlD
Tapentadol—OPRM1—brain—migraine	0.000198	0.00887	CbGeAlD
Tapentadol—SLC6A2—nervous system—migraine	0.00019	0.0085	CbGeAlD
Tapentadol—SLC6A2—central nervous system—migraine	0.000183	0.00818	CbGeAlD
Tapentadol—SLC6A4—brain—migraine	0.000165	0.00738	CbGeAlD
Tapentadol—Vomiting—Amitriptyline—migraine	0.000161	0.00159	CcSEcCtD
Tapentadol—Nervousness—Valproic Acid—migraine	0.00016	0.00158	CcSEcCtD
Tapentadol—Bradycardia—Gabapentin—migraine	0.00016	0.00158	CcSEcCtD
Tapentadol—Rash—Amitriptyline—migraine	0.00016	0.00158	CcSEcCtD
Tapentadol—Dermatitis—Amitriptyline—migraine	0.000159	0.00158	CcSEcCtD
Tapentadol—Headache—Amitriptyline—migraine	0.000159	0.00157	CcSEcCtD
Tapentadol—Abdominal discomfort—Topiramate—migraine	0.000158	0.00156	CcSEcCtD
Tapentadol—Eye disorder—Timolol—migraine	0.000157	0.00156	CcSEcCtD
Tapentadol—Cardiac disorder—Timolol—migraine	0.000156	0.00155	CcSEcCtD
Tapentadol—Feeling abnormal—Verapamil—migraine	0.000156	0.00154	CcSEcCtD
Tapentadol—Hypoaesthesia—Gabapentin—migraine	0.000156	0.00154	CcSEcCtD
Tapentadol—Hallucination—Gabapentin—migraine	0.000156	0.00154	CcSEcCtD
Tapentadol—Vision blurred—Valproic Acid—migraine	0.000155	0.00153	CcSEcCtD
Tapentadol—Urinary tract disorder—Gabapentin—migraine	0.000155	0.00153	CcSEcCtD
Tapentadol—Tremor—Valproic Acid—migraine	0.000154	0.00153	CcSEcCtD
Tapentadol—Connective tissue disorder—Gabapentin—migraine	0.000154	0.00152	CcSEcCtD
Tapentadol—Urethral disorder—Gabapentin—migraine	0.000154	0.00152	CcSEcCtD
Tapentadol—Upper respiratory tract infection—Topiramate—migraine	0.000153	0.00152	CcSEcCtD
Tapentadol—Angiopathy—Timolol—migraine	0.000153	0.00151	CcSEcCtD
Tapentadol—Pollakiuria—Topiramate—migraine	0.000152	0.00151	CcSEcCtD
Tapentadol—Immune system disorder—Timolol—migraine	0.000152	0.0015	CcSEcCtD
Tapentadol—Hypersensitivity—Propranolol—migraine	0.000152	0.0015	CcSEcCtD
Tapentadol—Erectile dysfunction—Topiramate—migraine	0.000152	0.0015	CcSEcCtD
Tapentadol—Mediastinal disorder—Timolol—migraine	0.000152	0.0015	CcSEcCtD
Tapentadol—Agitation—Valproic Acid—migraine	0.000151	0.0015	CcSEcCtD
Tapentadol—Visual impairment—Gabapentin—migraine	0.000151	0.00149	CcSEcCtD
Tapentadol—Urticaria—Verapamil—migraine	0.000151	0.00149	CcSEcCtD
Tapentadol—Angioedema—Valproic Acid—migraine	0.000151	0.00149	CcSEcCtD
Tapentadol—Nausea—Amitriptyline—migraine	0.00015	0.00149	CcSEcCtD
Tapentadol—Weight decreased—Topiramate—migraine	0.000149	0.00147	CcSEcCtD
Tapentadol—Vertigo—Valproic Acid—migraine	0.000148	0.00146	CcSEcCtD
Tapentadol—Asthenia—Propranolol—migraine	0.000148	0.00146	CcSEcCtD
Tapentadol—Mental disorder—Timolol—migraine	0.000148	0.00146	CcSEcCtD
Tapentadol—Infestation NOS—Topiramate—migraine	0.000147	0.00145	CcSEcCtD
Tapentadol—Infestation—Topiramate—migraine	0.000147	0.00145	CcSEcCtD
Tapentadol—Malnutrition—Timolol—migraine	0.000147	0.00145	CcSEcCtD
Tapentadol—Eye disorder—Gabapentin—migraine	0.000147	0.00145	CcSEcCtD
Tapentadol—Depression—Topiramate—migraine	0.000147	0.00145	CcSEcCtD
Tapentadol—Cardiac disorder—Gabapentin—migraine	0.000146	0.00144	CcSEcCtD
Tapentadol—Palpitations—Valproic Acid—migraine	0.000146	0.00144	CcSEcCtD
Tapentadol—SLC6A2—brain—migraine	0.000145	0.0065	CbGeAlD
Tapentadol—Tension—Timolol—migraine	0.000144	0.00142	CcSEcCtD
Tapentadol—Cough—Valproic Acid—migraine	0.000144	0.00142	CcSEcCtD
Tapentadol—Urinary tract infection—Topiramate—migraine	0.000143	0.00141	CcSEcCtD
Tapentadol—Nervousness—Timolol—migraine	0.000142	0.00141	CcSEcCtD
Tapentadol—Immune system disorder—Gabapentin—migraine	0.000142	0.0014	CcSEcCtD
Tapentadol—Mediastinal disorder—Gabapentin—migraine	0.000141	0.0014	CcSEcCtD
Tapentadol—Diarrhoea—Propranolol—migraine	0.000141	0.00139	CcSEcCtD
Tapentadol—Chills—Gabapentin—migraine	0.000141	0.00139	CcSEcCtD
Tapentadol—Arthralgia—Valproic Acid—migraine	0.00014	0.00139	CcSEcCtD
Tapentadol—Anxiety—Valproic Acid—migraine	0.00014	0.00138	CcSEcCtD
Tapentadol—Hypersensitivity—Verapamil—migraine	0.00014	0.00138	CcSEcCtD
Tapentadol—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—migraine	0.000139	0.00138	CcSEcCtD
Tapentadol—Vision blurred—Timolol—migraine	0.000138	0.00137	CcSEcCtD
Tapentadol—Mental disorder—Gabapentin—migraine	0.000137	0.00136	CcSEcCtD
Tapentadol—Dry mouth—Valproic Acid—migraine	0.000137	0.00136	CcSEcCtD
Tapentadol—Malnutrition—Gabapentin—migraine	0.000137	0.00135	CcSEcCtD
Tapentadol—Dizziness—Propranolol—migraine	0.000136	0.00135	CcSEcCtD
Tapentadol—Asthenia—Verapamil—migraine	0.000136	0.00134	CcSEcCtD
Tapentadol—Confusional state—Valproic Acid—migraine	0.000136	0.00134	CcSEcCtD
Tapentadol—Anaphylactic shock—Valproic Acid—migraine	0.000134	0.00133	CcSEcCtD
Tapentadol—Oedema—Valproic Acid—migraine	0.000134	0.00133	CcSEcCtD
Tapentadol—Bradycardia—Topiramate—migraine	0.000134	0.00133	CcSEcCtD
Tapentadol—Pruritus—Verapamil—migraine	0.000134	0.00133	CcSEcCtD
Tapentadol—Tension—Gabapentin—migraine	0.000134	0.00132	CcSEcCtD
Tapentadol—Angioedema—Timolol—migraine	0.000134	0.00132	CcSEcCtD
Tapentadol—Infection—Valproic Acid—migraine	0.000134	0.00132	CcSEcCtD
Tapentadol—Nervousness—Gabapentin—migraine	0.000133	0.00131	CcSEcCtD
Tapentadol—Nervous system disorder—Valproic Acid—migraine	0.000132	0.0013	CcSEcCtD
Tapentadol—Vertigo—Timolol—migraine	0.000132	0.0013	CcSEcCtD
Tapentadol—Syncope—Timolol—migraine	0.000132	0.0013	CcSEcCtD
Tapentadol—Hallucination—Topiramate—migraine	0.000131	0.0013	CcSEcCtD
Tapentadol—Hypoaesthesia—Topiramate—migraine	0.000131	0.0013	CcSEcCtD
Tapentadol—Tachycardia—Valproic Acid—migraine	0.000131	0.0013	CcSEcCtD
Tapentadol—Vomiting—Propranolol—migraine	0.000131	0.0013	CcSEcCtD
Tapentadol—Skin disorder—Valproic Acid—migraine	0.000131	0.00129	CcSEcCtD
Tapentadol—Urinary tract disorder—Topiramate—migraine	0.00013	0.00129	CcSEcCtD
Tapentadol—Hyperhidrosis—Valproic Acid—migraine	0.00013	0.00128	CcSEcCtD
Tapentadol—Rash—Propranolol—migraine	0.00013	0.00128	CcSEcCtD
Tapentadol—Dermatitis—Propranolol—migraine	0.00013	0.00128	CcSEcCtD
Tapentadol—Diarrhoea—Verapamil—migraine	0.00013	0.00128	CcSEcCtD
Tapentadol—Connective tissue disorder—Topiramate—migraine	0.00013	0.00128	CcSEcCtD
Tapentadol—Palpitations—Timolol—migraine	0.00013	0.00128	CcSEcCtD
Tapentadol—Urethral disorder—Topiramate—migraine	0.000129	0.00128	CcSEcCtD
Tapentadol—Loss of consciousness—Timolol—migraine	0.000129	0.00127	CcSEcCtD
Tapentadol—Vision blurred—Gabapentin—migraine	0.000129	0.00127	CcSEcCtD
Tapentadol—Cough—Timolol—migraine	0.000128	0.00127	CcSEcCtD
Tapentadol—Tremor—Gabapentin—migraine	0.000128	0.00126	CcSEcCtD
Tapentadol—Visual impairment—Topiramate—migraine	0.000127	0.00126	CcSEcCtD
Tapentadol—Hypotension—Valproic Acid—migraine	0.000126	0.00124	CcSEcCtD
Tapentadol—Agitation—Gabapentin—migraine	0.000126	0.00124	CcSEcCtD
Tapentadol—Dizziness—Verapamil—migraine	0.000125	0.00124	CcSEcCtD
Tapentadol—Arthralgia—Timolol—migraine	0.000125	0.00123	CcSEcCtD
Tapentadol—Angioedema—Gabapentin—migraine	0.000125	0.00123	CcSEcCtD
Tapentadol—Anxiety—Timolol—migraine	0.000124	0.00123	CcSEcCtD
Tapentadol—Unspecified disorder of skin and subcutaneous tissue—Timolol—migraine	0.000124	0.00123	CcSEcCtD
Tapentadol—Eye disorder—Topiramate—migraine	0.000123	0.00122	CcSEcCtD
Tapentadol—Vertigo—Gabapentin—migraine	0.000123	0.00121	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Valproic Acid—migraine	0.000123	0.00121	CcSEcCtD
Tapentadol—Cardiac disorder—Topiramate—migraine	0.000123	0.00121	CcSEcCtD
Tapentadol—Syncope—Gabapentin—migraine	0.000122	0.00121	CcSEcCtD
Tapentadol—Nausea—Propranolol—migraine	0.000122	0.00121	CcSEcCtD
Tapentadol—Dry mouth—Timolol—migraine	0.000122	0.00121	CcSEcCtD
Tapentadol—Insomnia—Valproic Acid—migraine	0.000122	0.0012	CcSEcCtD
Tapentadol—Paraesthesia—Valproic Acid—migraine	0.000121	0.00119	CcSEcCtD
Tapentadol—Palpitations—Gabapentin—migraine	0.000121	0.00119	CcSEcCtD
Tapentadol—Confusional state—Timolol—migraine	0.000121	0.00119	CcSEcCtD
Tapentadol—Vomiting—Verapamil—migraine	0.000121	0.00119	CcSEcCtD
Tapentadol—Loss of consciousness—Gabapentin—migraine	0.00012	0.00119	CcSEcCtD
Tapentadol—Dyspnoea—Valproic Acid—migraine	0.00012	0.00118	CcSEcCtD
Tapentadol—Angiopathy—Topiramate—migraine	0.00012	0.00118	CcSEcCtD
Tapentadol—Anaphylactic shock—Timolol—migraine	0.00012	0.00118	CcSEcCtD
Tapentadol—Oedema—Timolol—migraine	0.00012	0.00118	CcSEcCtD
Tapentadol—Rash—Verapamil—migraine	0.00012	0.00118	CcSEcCtD
Tapentadol—Somnolence—Valproic Acid—migraine	0.00012	0.00118	CcSEcCtD
Tapentadol—Dermatitis—Verapamil—migraine	0.000119	0.00118	CcSEcCtD
Tapentadol—Immune system disorder—Topiramate—migraine	0.000119	0.00118	CcSEcCtD
Tapentadol—Cough—Gabapentin—migraine	0.000119	0.00118	CcSEcCtD
Tapentadol—Mediastinal disorder—Topiramate—migraine	0.000119	0.00118	CcSEcCtD
Tapentadol—Infection—Timolol—migraine	0.000119	0.00118	CcSEcCtD
Tapentadol—Headache—Verapamil—migraine	0.000119	0.00117	CcSEcCtD
Tapentadol—Chills—Topiramate—migraine	0.000118	0.00117	CcSEcCtD
Tapentadol—Dyspepsia—Valproic Acid—migraine	0.000118	0.00117	CcSEcCtD
Tapentadol—Convulsion—Gabapentin—migraine	0.000118	0.00117	CcSEcCtD
Tapentadol—Shock—Timolol—migraine	0.000118	0.00116	CcSEcCtD
Tapentadol—Nervous system disorder—Timolol—migraine	0.000117	0.00116	CcSEcCtD
Tapentadol—Decreased appetite—Valproic Acid—migraine	0.000117	0.00116	CcSEcCtD
Tapentadol—Arthralgia—Gabapentin—migraine	0.000116	0.00115	CcSEcCtD
Tapentadol—Skin disorder—Timolol—migraine	0.000116	0.00115	CcSEcCtD
Tapentadol—Gastrointestinal disorder—Valproic Acid—migraine	0.000116	0.00115	CcSEcCtD
Tapentadol—Fatigue—Valproic Acid—migraine	0.000116	0.00115	CcSEcCtD
Tapentadol—Anxiety—Gabapentin—migraine	0.000116	0.00115	CcSEcCtD
Tapentadol—Hyperhidrosis—Timolol—migraine	0.000116	0.00114	CcSEcCtD
Tapentadol—Mental disorder—Topiramate—migraine	0.000116	0.00114	CcSEcCtD
Tapentadol—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—migraine	0.000115	0.00114	CcSEcCtD
Tapentadol—Constipation—Valproic Acid—migraine	0.000115	0.00114	CcSEcCtD
Tapentadol—Malnutrition—Topiramate—migraine	0.000115	0.00114	CcSEcCtD
Tapentadol—Dry mouth—Gabapentin—migraine	0.000114	0.00112	CcSEcCtD
Tapentadol—Tension—Topiramate—migraine	0.000113	0.00111	CcSEcCtD
Tapentadol—Nausea—Verapamil—migraine	0.000113	0.00111	CcSEcCtD
Tapentadol—Confusional state—Gabapentin—migraine	0.000112	0.00111	CcSEcCtD
Tapentadol—Hypotension—Timolol—migraine	0.000112	0.00111	CcSEcCtD
Tapentadol—Nervousness—Topiramate—migraine	0.000112	0.0011	CcSEcCtD
Tapentadol—Anaphylactic shock—Gabapentin—migraine	0.000111	0.0011	CcSEcCtD
Tapentadol—Oedema—Gabapentin—migraine	0.000111	0.0011	CcSEcCtD
Tapentadol—Feeling abnormal—Valproic Acid—migraine	0.000111	0.0011	CcSEcCtD
Tapentadol—Infection—Gabapentin—migraine	0.000111	0.00109	CcSEcCtD
Tapentadol—Shock—Gabapentin—migraine	0.00011	0.00108	CcSEcCtD
Tapentadol—CYP2D6—head—migraine	0.000109	0.00491	CbGeAlD
Tapentadol—Nervous system disorder—Gabapentin—migraine	0.000109	0.00108	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Timolol—migraine	0.000109	0.00108	CcSEcCtD
Tapentadol—Tachycardia—Gabapentin—migraine	0.000109	0.00108	CcSEcCtD
Tapentadol—Vision blurred—Topiramate—migraine	0.000108	0.00107	CcSEcCtD
Tapentadol—Skin disorder—Gabapentin—migraine	0.000108	0.00107	CcSEcCtD
Tapentadol—Insomnia—Timolol—migraine	0.000108	0.00107	CcSEcCtD
Tapentadol—Hyperhidrosis—Gabapentin—migraine	0.000108	0.00107	CcSEcCtD
Tapentadol—Tremor—Topiramate—migraine	0.000108	0.00106	CcSEcCtD
Tapentadol—Paraesthesia—Timolol—migraine	0.000107	0.00106	CcSEcCtD
Tapentadol—Urticaria—Valproic Acid—migraine	0.000107	0.00106	CcSEcCtD
Tapentadol—Dyspnoea—Timolol—migraine	0.000107	0.00105	CcSEcCtD
Tapentadol—Somnolence—Timolol—migraine	0.000106	0.00105	CcSEcCtD
Tapentadol—Agitation—Topiramate—migraine	0.000106	0.00104	CcSEcCtD
Tapentadol—Dyspepsia—Timolol—migraine	0.000105	0.00104	CcSEcCtD
Tapentadol—Hypotension—Gabapentin—migraine	0.000104	0.00103	CcSEcCtD
Tapentadol—Decreased appetite—Timolol—migraine	0.000104	0.00103	CcSEcCtD
Tapentadol—CYP2D6—nervous system—migraine	0.000104	0.00465	CbGeAlD
Tapentadol—Gastrointestinal disorder—Timolol—migraine	0.000103	0.00102	CcSEcCtD
Tapentadol—Vertigo—Topiramate—migraine	0.000103	0.00102	CcSEcCtD
Tapentadol—Fatigue—Timolol—migraine	0.000103	0.00102	CcSEcCtD
Tapentadol—Syncope—Topiramate—migraine	0.000103	0.00102	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Gabapentin—migraine	0.000102	0.001	CcSEcCtD
Tapentadol—Palpitations—Topiramate—migraine	0.000102	0.001	CcSEcCtD
Tapentadol—Loss of consciousness—Topiramate—migraine	0.000101	0.000998	CcSEcCtD
Tapentadol—Insomnia—Gabapentin—migraine	0.000101	0.000997	CcSEcCtD
Tapentadol—Cough—Topiramate—migraine	0.0001	0.000991	CcSEcCtD
Tapentadol—OPRD1—G alpha (i) signalling events—HTR1B—migraine	0.0001	0.00472	CbGpPWpGaD
Tapentadol—Paraesthesia—Gabapentin—migraine	0.0001	0.000989	CcSEcCtD
Tapentadol—OPRD1—GPCR ligand binding—HTR1D—migraine	0.0001	0.00471	CbGpPWpGaD
Tapentadol—CYP2D6—central nervous system—migraine	9.99e-05	0.00448	CbGeAlD
Tapentadol—Convulsion—Topiramate—migraine	9.96e-05	0.000984	CcSEcCtD
Tapentadol—Dyspnoea—Gabapentin—migraine	9.94e-05	0.000982	CcSEcCtD
Tapentadol—Somnolence—Gabapentin—migraine	9.91e-05	0.00098	CcSEcCtD
Tapentadol—Hypersensitivity—Valproic Acid—migraine	9.91e-05	0.000979	CcSEcCtD
Tapentadol—SLC6A4—Circadian rythm related genes—NPS—migraine	9.87e-05	0.00465	CbGpPWpGaD
Tapentadol—OPRK1—Peptide ligand-binding receptors—NPS—migraine	9.87e-05	0.00465	CbGpPWpGaD
Tapentadol—OPRK1—Peptide ligand-binding receptors—TAC1—migraine	9.87e-05	0.00465	CbGpPWpGaD
Tapentadol—Feeling abnormal—Timolol—migraine	9.86e-05	0.000975	CcSEcCtD
Tapentadol—Dyspepsia—Gabapentin—migraine	9.81e-05	0.00097	CcSEcCtD
Tapentadol—Arthralgia—Topiramate—migraine	9.78e-05	0.000967	CcSEcCtD
Tapentadol—CYP2D6—cerebellum—migraine	9.77e-05	0.00438	CbGeAlD
Tapentadol—Anxiety—Topiramate—migraine	9.75e-05	0.000964	CcSEcCtD
Tapentadol—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	9.74e-05	0.00459	CbGpPWpGaD
Tapentadol—Unspecified disorder of skin and subcutaneous tissue—Topiramate—migraine	9.72e-05	0.00096	CcSEcCtD
Tapentadol—Decreased appetite—Gabapentin—migraine	9.69e-05	0.000958	CcSEcCtD
Tapentadol—Asthenia—Valproic Acid—migraine	9.65e-05	0.000954	CcSEcCtD
Tapentadol—OPRD1—G alpha (i) signalling events—HTR1A—migraine	9.64e-05	0.00454	CbGpPWpGaD
Tapentadol—Gastrointestinal disorder—Gabapentin—migraine	9.62e-05	0.000951	CcSEcCtD
Tapentadol—Fatigue—Gabapentin—migraine	9.61e-05	0.00095	CcSEcCtD
Tapentadol—UGT2B7—NRF2 pathway—TGFBR2—migraine	9.58e-05	0.00451	CbGpPWpGaD
Tapentadol—Dry mouth—Topiramate—migraine	9.57e-05	0.000946	CcSEcCtD
Tapentadol—SLC6A2—Monoamine Transport—TNF—migraine	9.56e-05	0.0045	CbGpPWpGaD
Tapentadol—Constipation—Gabapentin—migraine	9.53e-05	0.000942	CcSEcCtD
Tapentadol—Pruritus—Valproic Acid—migraine	9.51e-05	0.00094	CcSEcCtD
Tapentadol—Urticaria—Timolol—migraine	9.51e-05	0.00094	CcSEcCtD
Tapentadol—Confusional state—Topiramate—migraine	9.46e-05	0.000935	CcSEcCtD
Tapentadol—SLC6A4—NRF2 pathway—TGFBR2—migraine	9.43e-05	0.00444	CbGpPWpGaD
Tapentadol—OPRK1—Peptide ligand-binding receptors—EDNRA—migraine	9.41e-05	0.00443	CbGpPWpGaD
Tapentadol—Oedema—Topiramate—migraine	9.38e-05	0.000927	CcSEcCtD
Tapentadol—Infection—Topiramate—migraine	9.32e-05	0.000921	CcSEcCtD
Tapentadol—OPRD1—GPCR ligand binding—HTR2B—migraine	9.3e-05	0.00438	CbGpPWpGaD
Tapentadol—OPRD1—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	9.29e-05	0.00438	CbGpPWpGaD
Tapentadol—Shock—Topiramate—migraine	9.23e-05	0.000912	CcSEcCtD
Tapentadol—Diarrhoea—Valproic Acid—migraine	9.2e-05	0.000909	CcSEcCtD
Tapentadol—Nervous system disorder—Topiramate—migraine	9.2e-05	0.000909	CcSEcCtD
Tapentadol—Feeling abnormal—Gabapentin—migraine	9.19e-05	0.000908	CcSEcCtD
Tapentadol—Tachycardia—Topiramate—migraine	9.15e-05	0.000905	CcSEcCtD
Tapentadol—Skin disorder—Topiramate—migraine	9.11e-05	0.0009	CcSEcCtD
Tapentadol—Hyperhidrosis—Topiramate—migraine	9.07e-05	0.000896	CcSEcCtD
Tapentadol—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	9.05e-05	0.00426	CbGpPWpGaD
Tapentadol—OPRD1—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	8.94e-05	0.00421	CbGpPWpGaD
Tapentadol—Dizziness—Valproic Acid—migraine	8.89e-05	0.000879	CcSEcCtD
Tapentadol—Urticaria—Gabapentin—migraine	8.85e-05	0.000875	CcSEcCtD
Tapentadol—SLC6A2—Transmembrane transport of small molecules—ATP1A2—migraine	8.82e-05	0.00416	CbGpPWpGaD
Tapentadol—SLC6A2—Transmembrane transport of small molecules—ATP1A3—migraine	8.82e-05	0.00416	CbGpPWpGaD
Tapentadol—Hypersensitivity—Timolol—migraine	8.82e-05	0.000872	CcSEcCtD
Tapentadol—OPRK1—G alpha (i) signalling events—HTR1B—migraine	8.78e-05	0.00414	CbGpPWpGaD
Tapentadol—OPRK1—GPCR ligand binding—HTR1D—migraine	8.77e-05	0.00413	CbGpPWpGaD
Tapentadol—Hypotension—Topiramate—migraine	8.76e-05	0.000866	CcSEcCtD
Tapentadol—OPRD1—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	8.64e-05	0.00407	CbGpPWpGaD
Tapentadol—SLC6A4—SIDS Susceptibility Pathways—BDNF—migraine	8.61e-05	0.00406	CbGpPWpGaD
Tapentadol—Asthenia—Timolol—migraine	8.59e-05	0.000849	CcSEcCtD
Tapentadol—Vomiting—Valproic Acid—migraine	8.55e-05	0.000845	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Topiramate—migraine	8.54e-05	0.000845	CcSEcCtD
Tapentadol—SLC6A4—Circadian rythm related genes—HTR7—migraine	8.48e-05	0.00399	CbGpPWpGaD
Tapentadol—Insomnia—Topiramate—migraine	8.48e-05	0.000838	CcSEcCtD
Tapentadol—Rash—Valproic Acid—migraine	8.48e-05	0.000838	CcSEcCtD
Tapentadol—Dermatitis—Valproic Acid—migraine	8.47e-05	0.000837	CcSEcCtD
Tapentadol—Pruritus—Timolol—migraine	8.47e-05	0.000837	CcSEcCtD
Tapentadol—OPRK1—G alpha (i) signalling events—HTR1A—migraine	8.45e-05	0.00398	CbGpPWpGaD
Tapentadol—Headache—Valproic Acid—migraine	8.42e-05	0.000833	CcSEcCtD
Tapentadol—Paraesthesia—Topiramate—migraine	8.42e-05	0.000832	CcSEcCtD
Tapentadol—OPRD1—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	8.4e-05	0.00396	CbGpPWpGaD
Tapentadol—Dyspnoea—Topiramate—migraine	8.36e-05	0.000826	CcSEcCtD
Tapentadol—OPRM1—Peptide ligand-binding receptors—NPS—migraine	8.34e-05	0.00393	CbGpPWpGaD
Tapentadol—OPRM1—Peptide ligand-binding receptors—TAC1—migraine	8.34e-05	0.00393	CbGpPWpGaD
Tapentadol—Somnolence—Topiramate—migraine	8.34e-05	0.000824	CcSEcCtD
Tapentadol—Dyspepsia—Topiramate—migraine	8.25e-05	0.000816	CcSEcCtD
Tapentadol—Hypersensitivity—Gabapentin—migraine	8.21e-05	0.000812	CcSEcCtD
Tapentadol—Diarrhoea—Timolol—migraine	8.19e-05	0.00081	CcSEcCtD
Tapentadol—OPRK1—GPCR ligand binding—HTR2B—migraine	8.16e-05	0.00384	CbGpPWpGaD
Tapentadol—Decreased appetite—Topiramate—migraine	8.15e-05	0.000806	CcSEcCtD
Tapentadol—OPRK1—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	8.15e-05	0.00384	CbGpPWpGaD
Tapentadol—SLC6A2—NRF2 pathway—TGFBR2—migraine	8.11e-05	0.00382	CbGpPWpGaD
Tapentadol—Gastrointestinal disorder—Topiramate—migraine	8.1e-05	0.0008	CcSEcCtD
Tapentadol—Fatigue—Topiramate—migraine	8.09e-05	0.000799	CcSEcCtD
Tapentadol—Constipation—Topiramate—migraine	8.02e-05	0.000793	CcSEcCtD
Tapentadol—Asthenia—Gabapentin—migraine	8e-05	0.000791	CcSEcCtD
Tapentadol—Nausea—Valproic Acid—migraine	7.99e-05	0.000789	CcSEcCtD
Tapentadol—OPRD1—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	7.96e-05	0.00375	CbGpPWpGaD
Tapentadol—OPRM1—Peptide ligand-binding receptors—EDNRA—migraine	7.95e-05	0.00375	CbGpPWpGaD
Tapentadol—CYP2D6—brain—migraine	7.93e-05	0.00356	CbGeAlD
Tapentadol—Dizziness—Timolol—migraine	7.92e-05	0.000782	CcSEcCtD
Tapentadol—Pruritus—Gabapentin—migraine	7.89e-05	0.00078	CcSEcCtD
Tapentadol—OPRK1—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	7.84e-05	0.00369	CbGpPWpGaD
Tapentadol—UGT1A9—NRF2 pathway—TGFBR2—migraine	7.79e-05	0.00367	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—CALCRL—migraine	7.78e-05	0.00367	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—RAMP1—migraine	7.78e-05	0.00367	CbGpPWpGaD
Tapentadol—Feeling abnormal—Topiramate—migraine	7.73e-05	0.000764	CcSEcCtD
Tapentadol—OPRD1—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	7.66e-05	0.00361	CbGpPWpGaD
Tapentadol—Diarrhoea—Gabapentin—migraine	7.63e-05	0.000754	CcSEcCtD
Tapentadol—Vomiting—Timolol—migraine	7.61e-05	0.000752	CcSEcCtD
Tapentadol—OPRK1—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	7.57e-05	0.00357	CbGpPWpGaD
Tapentadol—OPRD1—GPCRs, Class A Rhodopsin-like—HTR7—migraine	7.57e-05	0.00356	CbGpPWpGaD
Tapentadol—Rash—Timolol—migraine	7.55e-05	0.000746	CcSEcCtD
Tapentadol—OPRD1—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	7.55e-05	0.00355	CbGpPWpGaD
Tapentadol—OPRD1—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	7.55e-05	0.00355	CbGpPWpGaD
Tapentadol—Dermatitis—Timolol—migraine	7.54e-05	0.000745	CcSEcCtD
Tapentadol—SLC6A2—Transmembrane transport of small molecules—HTR3A—migraine	7.5e-05	0.00353	CbGpPWpGaD
Tapentadol—Headache—Timolol—migraine	7.5e-05	0.000741	CcSEcCtD
Tapentadol—Urticaria—Topiramate—migraine	7.45e-05	0.000736	CcSEcCtD
Tapentadol—OPRM1—G alpha (i) signalling events—HTR1B—migraine	7.42e-05	0.00349	CbGpPWpGaD
Tapentadol—OPRM1—GPCR ligand binding—HTR1D—migraine	7.42e-05	0.00349	CbGpPWpGaD
Tapentadol—OPRD1—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	7.4e-05	0.00349	CbGpPWpGaD
Tapentadol—Dizziness—Gabapentin—migraine	7.37e-05	0.000729	CcSEcCtD
Tapentadol—OPRK1—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	7.37e-05	0.00347	CbGpPWpGaD
Tapentadol—OPRM1—TCR Signaling Pathway—FOS—migraine	7.29e-05	0.00344	CbGpPWpGaD
Tapentadol—SLC6A4—SIDS Susceptibility Pathways—HTR2A—migraine	7.28e-05	0.00343	CbGpPWpGaD
Tapentadol—OPRD1—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	7.2e-05	0.00339	CbGpPWpGaD
Tapentadol—OPRM1—G alpha (i) signalling events—HTR1A—migraine	7.14e-05	0.00336	CbGpPWpGaD
Tapentadol—Nausea—Timolol—migraine	7.11e-05	0.000703	CcSEcCtD
Tapentadol—Vomiting—Gabapentin—migraine	7.09e-05	0.000701	CcSEcCtD
Tapentadol—OPRD1—Signaling by GPCR—RAMP1—migraine	7.07e-05	0.00333	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—CALCRL—migraine	7.07e-05	0.00333	CbGpPWpGaD
Tapentadol—Rash—Gabapentin—migraine	7.03e-05	0.000695	CcSEcCtD
Tapentadol—Dermatitis—Gabapentin—migraine	7.02e-05	0.000694	CcSEcCtD
Tapentadol—Headache—Gabapentin—migraine	6.98e-05	0.00069	CcSEcCtD
Tapentadol—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	6.98e-05	0.00329	CbGpPWpGaD
Tapentadol—Hypersensitivity—Topiramate—migraine	6.91e-05	0.000683	CcSEcCtD
Tapentadol—OPRM1—GPCR ligand binding—HTR2B—migraine	6.89e-05	0.00325	CbGpPWpGaD
Tapentadol—OPRM1—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	6.89e-05	0.00324	CbGpPWpGaD
Tapentadol—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TNF—migraine	6.86e-05	0.00323	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—RAMP1—migraine	6.82e-05	0.00321	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—CALCRL—migraine	6.82e-05	0.00321	CbGpPWpGaD
Tapentadol—Asthenia—Topiramate—migraine	6.73e-05	0.000665	CcSEcCtD
Tapentadol—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	6.72e-05	0.00316	CbGpPWpGaD
Tapentadol—Pruritus—Topiramate—migraine	6.63e-05	0.000656	CcSEcCtD
Tapentadol—OPRK1—GPCRs, Class A Rhodopsin-like—HTR7—migraine	6.63e-05	0.00312	CbGpPWpGaD
Tapentadol—OPRM1—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	6.63e-05	0.00312	CbGpPWpGaD
Tapentadol—Nausea—Gabapentin—migraine	6.62e-05	0.000654	CcSEcCtD
Tapentadol—OPRK1—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	6.62e-05	0.00312	CbGpPWpGaD
Tapentadol—OPRK1—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	6.62e-05	0.00312	CbGpPWpGaD
Tapentadol—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	6.49e-05	0.00306	CbGpPWpGaD
Tapentadol—OPRD1—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	6.48e-05	0.00305	CbGpPWpGaD
Tapentadol—Diarrhoea—Topiramate—migraine	6.42e-05	0.000634	CcSEcCtD
Tapentadol—OPRM1—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	6.4e-05	0.00302	CbGpPWpGaD
Tapentadol—OPRK1—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	6.31e-05	0.00297	CbGpPWpGaD
Tapentadol—OPRM1—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	6.23e-05	0.00293	CbGpPWpGaD
Tapentadol—Dizziness—Topiramate—migraine	6.2e-05	0.000613	CcSEcCtD
Tapentadol—OPRK1—Signaling by GPCR—RAMP1—migraine	6.2e-05	0.00292	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—CALCRL—migraine	6.2e-05	0.00292	CbGpPWpGaD
Tapentadol—OPRD1—GPCR ligand binding—HTR1B—migraine	6.06e-05	0.00286	CbGpPWpGaD
Tapentadol—Vomiting—Topiramate—migraine	5.96e-05	0.000589	CcSEcCtD
Tapentadol—Rash—Topiramate—migraine	5.91e-05	0.000584	CcSEcCtD
Tapentadol—Dermatitis—Topiramate—migraine	5.91e-05	0.000584	CcSEcCtD
Tapentadol—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	5.9e-05	0.00278	CbGpPWpGaD
Tapentadol—Headache—Topiramate—migraine	5.87e-05	0.000581	CcSEcCtD
Tapentadol—OPRD1—GPCR ligand binding—HTR1A—migraine	5.84e-05	0.00275	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—RAMP1—migraine	5.77e-05	0.00272	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—CALCRL—migraine	5.77e-05	0.00272	CbGpPWpGaD
Tapentadol—OPRD1—GPCR ligand binding—TAC1—migraine	5.75e-05	0.00271	CbGpPWpGaD
Tapentadol—OPRD1—GPCR ligand binding—NPS—migraine	5.75e-05	0.00271	CbGpPWpGaD
Tapentadol—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	5.68e-05	0.00268	CbGpPWpGaD
Tapentadol—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	5.68e-05	0.00267	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—HTR1D—migraine	5.65e-05	0.00266	CbGpPWpGaD
Tapentadol—OPRD1—GPCR ligand binding—HTR2C—migraine	5.64e-05	0.00265	CbGpPWpGaD
Tapentadol—OPRM1—GPCRs, Class A Rhodopsin-like—HTR7—migraine	5.61e-05	0.00264	CbGpPWpGaD
Tapentadol—OPRM1—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	5.59e-05	0.00263	CbGpPWpGaD
Tapentadol—OPRM1—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	5.59e-05	0.00263	CbGpPWpGaD
Tapentadol—Nausea—Topiramate—migraine	5.57e-05	0.000551	CcSEcCtD
Tapentadol—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	5.48e-05	0.00258	CbGpPWpGaD
Tapentadol—OPRD1—GPCR ligand binding—EDNRA—migraine	5.48e-05	0.00258	CbGpPWpGaD
Tapentadol—OPRM1—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	5.34e-05	0.00251	CbGpPWpGaD
Tapentadol—OPRK1—GPCR ligand binding—HTR1B—migraine	5.32e-05	0.0025	CbGpPWpGaD
Tapentadol—OPRD1—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	5.3e-05	0.0025	CbGpPWpGaD
Tapentadol—OPRD1—GPCR ligand binding—CALCA—migraine	5.28e-05	0.00249	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—HTR2B—migraine	5.26e-05	0.00248	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—CALCRL—migraine	5.24e-05	0.00247	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—RAMP1—migraine	5.24e-05	0.00247	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—HTR1D—migraine	5.13e-05	0.00242	CbGpPWpGaD
Tapentadol—OPRK1—GPCR ligand binding—HTR1A—migraine	5.12e-05	0.00241	CbGpPWpGaD
Tapentadol—OPRK1—GPCR ligand binding—NPS—migraine	5.04e-05	0.00237	CbGpPWpGaD
Tapentadol—OPRK1—GPCR ligand binding—TAC1—migraine	5.04e-05	0.00237	CbGpPWpGaD
Tapentadol—HTR3A—SIDS Susceptibility Pathways—TNF—migraine	5.01e-05	0.00236	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—HTR1D—migraine	4.96e-05	0.00234	CbGpPWpGaD
Tapentadol—OPRK1—GPCR ligand binding—HTR2C—migraine	4.94e-05	0.00233	CbGpPWpGaD
Tapentadol—OPRD1—GPCR ligand binding—HTR7—migraine	4.94e-05	0.00232	CbGpPWpGaD
Tapentadol—OPRK1—GPCR ligand binding—EDNRA—migraine	4.81e-05	0.00226	CbGpPWpGaD
Tapentadol—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	4.8e-05	0.00226	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—HTR2B—migraine	4.77e-05	0.00225	CbGpPWpGaD
Tapentadol—OPRK1—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	4.65e-05	0.00219	CbGpPWpGaD
Tapentadol—OPRK1—GPCR ligand binding—CALCA—migraine	4.63e-05	0.00218	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—HTR2B—migraine	4.61e-05	0.00217	CbGpPWpGaD
Tapentadol—OPRD1—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	4.54e-05	0.00214	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—HTR1D—migraine	4.5e-05	0.00212	CbGpPWpGaD
Tapentadol—OPRM1—GPCR ligand binding—HTR1B—migraine	4.49e-05	0.00212	CbGpPWpGaD
Tapentadol—OPRK1—GPCR ligand binding—HTR7—migraine	4.33e-05	0.00204	CbGpPWpGaD
Tapentadol—OPRM1—GPCR ligand binding—HTR1A—migraine	4.32e-05	0.00204	CbGpPWpGaD
Tapentadol—OPRM1—GPCR ligand binding—TAC1—migraine	4.26e-05	0.00201	CbGpPWpGaD
Tapentadol—OPRM1—GPCR ligand binding—NPS—migraine	4.26e-05	0.00201	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—HTR1D—migraine	4.19e-05	0.00197	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—HTR2B—migraine	4.19e-05	0.00197	CbGpPWpGaD
Tapentadol—OPRM1—GPCR ligand binding—HTR2C—migraine	4.18e-05	0.00197	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—RAMP1—migraine	4.17e-05	0.00197	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—CALCRL—migraine	4.17e-05	0.00197	CbGpPWpGaD
Tapentadol—OPRM1—GPCR ligand binding—EDNRA—migraine	4.06e-05	0.00191	CbGpPWpGaD
Tapentadol—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	3.98e-05	0.00188	CbGpPWpGaD
Tapentadol—OPRM1—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	3.93e-05	0.00185	CbGpPWpGaD
Tapentadol—OPRM1—GPCR ligand binding—CALCA—migraine	3.91e-05	0.00184	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—HTR2B—migraine	3.9e-05	0.00183	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—HTR1D—migraine	3.81e-05	0.00179	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—RAMP1—migraine	3.66e-05	0.00172	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—CALCRL—migraine	3.66e-05	0.00172	CbGpPWpGaD
Tapentadol—OPRM1—GPCR ligand binding—HTR7—migraine	3.66e-05	0.00172	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—HTR2B—migraine	3.54e-05	0.00167	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—CACNA1A—migraine	3.53e-05	0.00166	CbGpPWpGaD
Tapentadol—OPRD1—GPCR ligand binding—HTR2A—migraine	3.46e-05	0.00163	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—HTR1B—migraine	3.43e-05	0.00161	CbGpPWpGaD
Tapentadol—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	3.36e-05	0.00158	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—HTR1A—migraine	3.3e-05	0.00155	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—NPS—migraine	3.25e-05	0.00153	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—TAC1—migraine	3.25e-05	0.00153	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—HTR2C—migraine	3.18e-05	0.0015	CbGpPWpGaD
Tapentadol—SLC6A4—SIDS Susceptibility Pathways—TNF—migraine	3.13e-05	0.00147	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—HTR1B—migraine	3.11e-05	0.00147	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—EDNRA—migraine	3.1e-05	0.00146	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—RAMP1—migraine	3.09e-05	0.00146	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—CALCRL—migraine	3.09e-05	0.00146	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—HTR1D—migraine	3.03e-05	0.00143	CbGpPWpGaD
Tapentadol—OPRK1—GPCR ligand binding—HTR2A—migraine	3.03e-05	0.00143	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—HTR1B—migraine	3e-05	0.00141	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—HTR1A—migraine	2.99e-05	0.00141	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—CALCA—migraine	2.98e-05	0.0014	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—TAC1—migraine	2.95e-05	0.00139	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—NPS—migraine	2.95e-05	0.00139	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—HTR2C—migraine	2.89e-05	0.00136	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—HTR1A—migraine	2.89e-05	0.00136	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—CACNA1A—migraine	2.87e-05	0.00135	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—TAC1—migraine	2.85e-05	0.00134	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—NPS—migraine	2.85e-05	0.00134	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—HTR2B—migraine	2.82e-05	0.00133	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—EDNRA—migraine	2.81e-05	0.00133	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—HTR2C—migraine	2.79e-05	0.00132	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—HTR7—migraine	2.79e-05	0.00131	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—HTR1B—migraine	2.73e-05	0.00128	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—EDNRA—migraine	2.72e-05	0.00128	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—CALCA—migraine	2.71e-05	0.00128	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—HTR1D—migraine	2.66e-05	0.00125	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—HTR1A—migraine	2.63e-05	0.00124	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—CALCA—migraine	2.62e-05	0.00123	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—TAC1—migraine	2.59e-05	0.00122	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—NPS—migraine	2.59e-05	0.00122	CbGpPWpGaD
Tapentadol—OPRM1—GPCR ligand binding—HTR2A—migraine	2.56e-05	0.00121	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—HTR1B—migraine	2.54e-05	0.0012	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—HTR2C—migraine	2.54e-05	0.00119	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—HTR7—migraine	2.53e-05	0.00119	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—LRP1—migraine	2.48e-05	0.00117	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—HTR2B—migraine	2.47e-05	0.00116	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—EDNRA—migraine	2.47e-05	0.00116	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—HTR7—migraine	2.45e-05	0.00115	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—HTR1A—migraine	2.44e-05	0.00115	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—NPS—migraine	2.41e-05	0.00113	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—TAC1—migraine	2.41e-05	0.00113	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—CALCA—migraine	2.37e-05	0.00112	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—HTR2C—migraine	2.36e-05	0.00111	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—HTR1B—migraine	2.31e-05	0.00109	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—EDNRA—migraine	2.3e-05	0.00108	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—HTR1D—migraine	2.25e-05	0.00106	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—HTR7—migraine	2.22e-05	0.00105	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—HTR1A—migraine	2.22e-05	0.00105	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—CALCA—migraine	2.21e-05	0.00104	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—NPS—migraine	2.19e-05	0.00103	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—TAC1—migraine	2.19e-05	0.00103	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—LRP1—migraine	2.18e-05	0.00103	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—HTR2C—migraine	2.14e-05	0.00101	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—HTR2B—migraine	2.09e-05	0.000984	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—EDNRA—migraine	2.09e-05	0.000982	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—HTR7—migraine	2.07e-05	0.000974	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—CALCA—migraine	2.01e-05	0.000945	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—HTR2A—migraine	1.95e-05	0.00092	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—NOTCH4—migraine	1.9e-05	0.000897	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—HTR7—migraine	1.88e-05	0.000884	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—LRP1—migraine	1.84e-05	0.000867	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—HTR1B—migraine	1.84e-05	0.000866	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—HTR2A—migraine	1.77e-05	0.000836	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—HTR1A—migraine	1.77e-05	0.000833	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—TAC1—migraine	1.74e-05	0.000821	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—NPS—migraine	1.74e-05	0.000821	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—PGR—migraine	1.74e-05	0.000821	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—HTR2A—migraine	1.71e-05	0.000807	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—HTR2C—migraine	1.71e-05	0.000805	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—NOTCH4—migraine	1.67e-05	0.000787	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—EDNRA—migraine	1.66e-05	0.000783	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—NOTCH3—migraine	1.62e-05	0.000763	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—HTR1B—migraine	1.61e-05	0.000759	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—CALCA—migraine	1.6e-05	0.000754	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—HTR2A—migraine	1.56e-05	0.000733	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—HTR1A—migraine	1.55e-05	0.000731	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—NPS—migraine	1.53e-05	0.00072	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—TAC1—migraine	1.53e-05	0.00072	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—PGR—migraine	1.53e-05	0.00072	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—HTR2C—migraine	1.5e-05	0.000706	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—HTR7—migraine	1.5e-05	0.000705	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—EDNRA—migraine	1.46e-05	0.000686	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—HTR2A—migraine	1.45e-05	0.000682	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—NOTCH3—migraine	1.42e-05	0.000669	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—NOTCH4—migraine	1.41e-05	0.000665	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—CALCA—migraine	1.4e-05	0.000661	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—HTR1B—migraine	1.36e-05	0.000641	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—CACNA1A—migraine	1.35e-05	0.000635	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—HTR2A—migraine	1.31e-05	0.000619	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—HTR7—migraine	1.31e-05	0.000618	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—HTR1A—migraine	1.31e-05	0.000617	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—TAC1—migraine	1.29e-05	0.000608	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—NPS—migraine	1.29e-05	0.000608	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—PGR—migraine	1.29e-05	0.000608	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—TGFBR2—migraine	1.29e-05	0.000607	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—HTR2C—migraine	1.27e-05	0.000596	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—CACNA1A—migraine	1.24e-05	0.000584	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—EDNRA—migraine	1.23e-05	0.00058	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—CACNA1A—migraine	1.23e-05	0.000579	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—NOTCH3—migraine	1.2e-05	0.000565	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—CALCA—migraine	1.19e-05	0.000558	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—MTHFR—migraine	1.17e-05	0.00055	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—TGFBR2—migraine	1.13e-05	0.000532	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—HTR7—migraine	1.11e-05	0.000522	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—HTR2A—migraine	1.05e-05	0.000494	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—TGFBR2—migraine	9.55e-06	0.00045	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—MTHFR—migraine	9.49e-06	0.000447	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—ESR1—migraine	9.3e-06	0.000438	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—HTR2A—migraine	9.19e-06	0.000433	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—ESR1—migraine	8.16e-06	0.000384	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—HTR2A—migraine	7.77e-06	0.000366	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—ESR1—migraine	6.89e-06	0.000325	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—MTHFR—migraine	4.46e-06	0.00021	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—MTHFR—migraine	4.1e-06	0.000193	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—MTHFR—migraine	4.07e-06	0.000191	CbGpPWpGaD
